MESALAZINE PLACE IN THERAPY OF ULCERATIVE COLITIS

Abstract

Preparations of 5-aminosalycil acid (Mesalazine) are used as the first-line therapy to induce remission if the UC activity is minimal and as the priority drugs for anti-recurrence therapy of patients with UC and are included in the Russian recommendations on the therapy of the colitis of the slight and moderate activity. The choice of the drug and its form requires individual approach, it must be based on the UC duration, activity of the inflammatory process as of the moment of the treatment decision taking, the drug safety profile, its effectiveness and tolerability.

Keywords

• ulcerous colitis
• mesalazine
• 5-aminosalycil acid
• remission induction
• anti-recurrence therapy